“Given that the AIDS pandemic has been around for 30 years …, the long-awaited goal [of developing an HIV vaccine] might finally be attainable, according to researchers attending the AIDS Vaccine 2013 conference last week in Barcelona,” Scientific American reports in an article summarizing clinical trial findings presented at the conference. “The future will probably … see much greater cooperation among the various camps within the field: vaccinologists and pathogenicists, preventive and therapeutic vaccines, vaccine and microbicide approaches,” the magazine writes, noting, “As a matter of fact, the Barcelona meeting was the last AIDS Vaccine conference.” Scientific American adds, “Next year the gathering will be called the HIV Research for Prevention Conference (H4P) and will bring together the fields of vaccines, microbicides and antiretroviral drugs” (Furtado, 10/18).